Abstracts - faqs.org

Abstracts

Zoology and wildlife conservation

Search abstracts:
Abstracts » Zoology and wildlife conservation

A transformed view of cyclosporine

Article Abstract:

Cyclosporine and the related FK506, are used to treat autoimmune diseases and prevent organ rejection in transplants. Hojo and colleagues describe a re-examination of the presumed causes of cyclosporine-associated cancers, and find that cyclosporine changes the characteristics of certain cancerous cell lines in vitro and in vivo. This is thought to be achieved by inducing the synthesis of transforming growth factor-beta (TGF-Beta). However it is still not known whether it has a similar effect on precancerous cells, or whether it has a role in converting cells from benign to cancerous states.

Author: Nabel, Gary J.
Publisher: Macmillan Publishing Ltd.
Publication Name: Nature
Subject: Zoology and wildlife conservation
ISSN: 0028-0836
Year: 1999
Cancer research, Cancer

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Cyclosporine induces cancer progression by a cell-autonomous mechanism

Article Abstract:

A mechanism is reported for the heightened malignancy independent of host immunity. Cyclosporine, an immunosuppressant, induces phenotypic changes following organ transplantation. Cyclosporine treatment of adenocarcinoma cells leads to dramatic morphological alternations, such as membrane ruffling, pseudopodial protrusions and increased cell motility. Treatment with monoclonal antibodies directed at transforming growth factor-beta prevents these changes.

Author: Morimoto, Kengo, Suthanthiran, Manikkam, Morimoto, Takashi, Hojo, Minoru, Maluccio, Mary, Asano, Tomohiko, Lagman, Milagros, Shimbo, Toshikazu
Publisher: Macmillan Publishing Ltd.
Publication Name: Nature
Subject: Zoology and wildlife conservation
ISSN: 0028-0836
Year: 1999
Observations, Immunosuppression

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


A diffusible coupling signal from the transplanted suprachiasmatic nucleus controlling circadian locomotor rhythms

Article Abstract:

Transplanted suprachiasmatic nuclei (SCN), like neural pacemakers of silkmoths and Drosophila, restore circadian activity rhythms through a diffusible signal in animals whose own SCN have been ablated. This shows that the circadian rhythm is a result of the donor tissue rather than a consequence of spontaneous recovery of function. Re-establishment of appropriate synaptic connections and neural efferents is necessary for circadian rhythmicity.

Author: Silver, Rae, LeSauter, Joseph, Tresco, Patrick A., Lehman, Michael N.
Publisher: Macmillan Publishing Ltd.
Publication Name: Nature
Subject: Zoology and wildlife conservation
ISSN: 0028-0836
Year: 1996
Circadian rhythms

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Research, Transplantation of organs, tissues, etc., Organ transplantation, Tissue transplantation, Transplantation, Cyclosporine, Cyclosporins
Similar abstracts:
  • Abstracts: Electrons held in a queue. Isotope-induced partial localization of core electrons in the homonuclear molecule N2.
  • Abstracts: Attractiveness of scents varies with protein content of the diet in meadow voles. The response of native Australian rodents to predator odours varies seasonally: a by-product of life history variation?
  • Abstracts: Mode of colony foundation influences the primary sex ratio in ants. Primary and secondary sex ratios in monogyne colonies of the fire ant
  • Abstracts: Identification of a new type of electronic state in the magnetoresistive orthomanganites. Heavy oxygen tips the balance
  • Abstracts: Altered immune responses in mice lacking inducible nitric oxide synthase. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.